A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle disease

Citation
R. Fernandez et al., A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle disease, ARCH NEUROL, 57(2), 2000, pp. 217-219
Citations number
26
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
ARCHIVES OF NEUROLOGY
ISSN journal
00039942 → ACNP
Volume
57
Issue
2
Year of publication
2000
Pages
217 - 219
Database
ISI
SICI code
0003-9942(200002)57:2<217:ANMM(I>2.0.ZU;2-1
Abstract
Objective: To investigate the degree of genetic heterogeneity of myophospho rylase deficiency (McArdle disease) in Spain through molecular studies of 1 0 new patients. Design: The coding sequence of the entire myophosphorylase gene was sequenc ed in DNA extracted from muscle and blood. Restriction fragment length poly morphism analysis of polymerase chain reaction fragments was used to confir m and simplify detection of a novel mutation. Setting: A collaborative study between 2 university laboratories in Spain a nd the United States. Results: Five of the 10 patients harbored a novel missense mutation in exon 20, converting a tryptophan to an arginine (W797R). Three patients were ho mozygous for the ''common" R49X mutation, and the remaining 2 patients were compound heterozygotes for R49X and a previously described missense mutati on, G204S. Conclusions: The W797R missense mutation is the third novel mutation to be identified among Spanish patients. Its relative frequency suggests that it should be added to the R49X mutation in the molecular screening of McArdle disease in Spain.